These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1841756)

  • 21. Mechanisms of metastasis suppression by introduction of human chromosome 10 into rat prostate cancer.
    Hamano M; Kuramochi H; Nihei N; Kamiya N; Suzuki H; Igarashi T; Barrett JC; Ichikawa T; Ito H
    Asian J Androl; 2002 Jun; 4(2):123-9. PubMed ID: 12085103
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Longitudinal evaluation of cytogenetic aberrations in prostatic cancer: tumours that recur in time display an intermediate genetic status between non-persistent and metastatic tumours.
    Alers JC; Krijtenburg PJ; Hop WC; Bolle WA; Schröder FH; van der Kwast TH; Bosman FT; van Dekken H
    J Pathol; 1998 Jul; 185(3):273-83. PubMed ID: 9771481
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chromosome 17-mediated dormancy of AT6.1 prostate cancer micrometastases.
    Chekmareva MA; Kadkhodaian MM; Hollowell CM; Kim H; Yoshida BA; Luu HH; Stadler WM; Rinker-Schaeffer CW
    Cancer Res; 1998 Nov; 58(21):4963-9. PubMed ID: 9810006
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Search for metastasis suppressor genes.
    Steeg PS
    Invasion Metastasis; 1989; 9(6):351-9. PubMed ID: 2532185
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Defining the critical gene expression changes associated with expression and suppression of the tumorigenic and metastatic phenotype in Ha-ras-transformed cloned rat embryo fibroblast cells.
    Su ZZ; Austin VN; Zimmer SG; Fisher PB
    Oncogene; 1993 May; 8(5):1211-9. PubMed ID: 8479744
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microcell-mediated transfer of chromosome 6 into metastatic human C8161 melanoma cells suppresses metastasis but does not inhibit tumorigenicity.
    Welch DR; Chen P; Miele ME; McGary CT; Bower JM; Stanbridge EJ; Weissman BE
    Oncogene; 1994 Jan; 9(1):255-62. PubMed ID: 8302587
    [TBL] [Abstract][Full Text] [Related]  

  • 27. H-ras expression, genetic instability, and acquisition of metastatic ability by rat prostatic cancer cells following v-H-ras oncogene transfection.
    Ichikawa T; Schalken JA; Ichikawa Y; Steinberg GD; Isaacs JT
    Prostate; 1991; 18(2):163-72. PubMed ID: 2006121
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metastatic potential of cloned murine melanoma cells transfected with activated c-Ha-ras.
    Price JE; Aukerman SL; Ananthaswamy HN; McIntyre BW; Schackert G; Schackert HK; Fidler IJ
    Cancer Res; 1989 Aug; 49(15):4274-81. PubMed ID: 2663141
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interphase cytogenetics of prostatic tumor progression: specific chromosomal abnormalities are involved in metastasis to the bone.
    Alers JC; Krijtenburg PJ; Rosenberg C; Hop WC; Verkerk AM; Schröder FH; van der Kwast TH; Bosman FT; van Dekken H
    Lab Invest; 1997 Nov; 77(5):437-48. PubMed ID: 9389787
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metastatic potential prediction by a visual grading system of cell motility: prospective validation in the Dunning R-3327 prostatic adenocarcinoma model.
    Mohler JL; Partin AW; Isaacs JT; Coffey DS
    Cancer Res; 1988 Aug; 48(15):4312-7. PubMed ID: 3390827
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Suppression of MDA-MB-435 breast carcinoma cell metastasis following the introduction of human chromosome 11.
    Phillips KK; Welch DR; Miele ME; Lee JH; Wei LL; Weissman BE
    Cancer Res; 1996 Mar; 56(6):1222-7. PubMed ID: 8640802
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inserting chromosome 18 into pancreatic cancer cells switches them to a dormant metastatic phenotype.
    Lefter LP; Sunamura M; Furukawa T; Takeda K; Kotobuki N; Oshimura M; Matsuno S; Horii A
    Clin Cancer Res; 2003 Oct; 9(13):5044-52. PubMed ID: 14581380
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overexpression of the c-erbB-2 gene enhanced intrinsic metastasis potential in human breast cancer cells without increasing their transformation abilities.
    Tan M; Yao J; Yu D
    Cancer Res; 1997 Mar; 57(6):1199-205. PubMed ID: 9067293
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The investigation of the technology of microcell mediated chromosome transfer for functional localization of metastasis suppressor genes for liver cancer on human chromosomes].
    Liu H; Ye SL; Yang J; Tang ZY; Liu YK; Qin LX; Qiu SJ; Sun RX
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Oct; 23(5):540-3. PubMed ID: 17029204
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biochemical methods for predicting metastatic ability of prostatic cancer utilizing the dunning R-3327 rat prostatic adenocarcinoma system as a model.
    Lowe FC; Isaacs JT
    Cancer Res; 1984 Feb; 44(2):744-52. PubMed ID: 6537899
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The characterization of a newly identified, highly metastatic variety of Dunning R 3327 rat prostatic adenocarcinoma system: the MAT LyLu tumor.
    Isaacs JT; Yu GW; Coffey DS
    Invest Urol; 1981 Jul; 19(1):20-3. PubMed ID: 7251319
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prostate cancer metastasis-suppressor genes: a current perspective.
    Yoshida BA; Chekmareva MA; Wharam JF; Kadkhodaian M; Stadler WM; Boyer A; Watabe K; Nelson JB; Rinker-Schaeffer CW
    In Vivo; 1998; 12(1):49-58. PubMed ID: 9575426
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Down modulation of fibronectin messenger RNA in metastasizing rat prostatic cancer cells revealed by differential hybridization analysis.
    Schalken JA; Ebeling SB; Isaacs JT; Treiger B; Bussemakers MJ; de Jong ME; Van de Ven WJ
    Cancer Res; 1988 Apr; 48(8):2042-6. PubMed ID: 3349475
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Src-suppressed C kinase substrate, SSeCKS, is a potential metastasis inhibitor in prostate cancer.
    Xia W; Unger P; Miller L; Nelson J; Gelman IH
    Cancer Res; 2001 Jul; 61(14):5644-51. PubMed ID: 11454719
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of bcl-2 and the progression of human and rodent prostatic cancers.
    Furuya Y; Krajewski S; Epstein JI; Reed JC; Isaacs JT
    Clin Cancer Res; 1996 Feb; 2(2):389-98. PubMed ID: 9816182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.